Posted by: admin on: December 8, 2011
A femoral artery closure device may reduce large hematomas and speed closure compared with manual compression of the catheter access wound, a randomized trial indicated. Inhospital hematomas larger than 5 cm occurred in 2.2% of patients treated with the FemoSeal device compared with a hematoma rate of 6.7% in patients treated with manual compression alone
Posted by: admin on: December 5, 2011
ARBs are the most commonly used Antihypertensives because of their renal protective benefit. But here is a new study stating its cardiac risk & cancer susceptablity. But if benefit out weighs their safety concerns we still have the choice. Team@CMHF
Posted by: admin on: November 28, 2011
Anti platelet agents are important to prevent CVD. Recent study suggests that low on-clopidogrel platelet reactivity linked to reduced CV event risk. Team@CMHF
Posted by: admin on: November 25, 2011
Selection of the stent is important for the outcome of angioplasty. A study suggests that DES is better choice than BMS, especially in saphenous vein graft lesion patients. Team@CMHF
Posted by: admin on: November 25, 2011
It has been noted that antioxidants play a role in reducing CVD. A recent study shows that they are effective in reducing AF, arrhythmia after cardiac surgery. Team@CMHF